In-hospital and 12-month postprocedural clinical outcome of coronary bifurcational lesion treatment with the endeavor stent

Journal of Interventional Cardiology

Volumn 23, Issue 2, 2010, Pages 188-194

  Fernández Guerrero, Juan Carlos ^a   Herrador Fuentes, Juan ^a   Sánchez Gila, Joaquin ^a   Guzmán Herrera, Manuel ^a   Lozano, Cristóbal ^a  

^a Servicio de Cardiologia   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ZOTAROLIMUS;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY LESION; ARTICLE; BARE METAL STENT; CAUSE OF DEATH; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HOSPITAL PATIENT; HUMAN; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DRUG-ELUTING STENTS; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HUMANS; INPATIENTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77950576531     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2010.00538.x     Document Type: Article

References (25)

1. Al Suwaidi J, Yeh W, Cohen HA, et al. Immediate and one-year outcome in patients with coronary bifurcation lesions in the modern era. Am J Cardiol 2001 87 : 1139 1144.
2. Al Suwaidi J, Berger PB, Rihal CS, et al. Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions. J Am Coll Cardiol 2000 35 : 929 936.
3. Routledge HC, Morice M-C, Lefèvre T, et al. 2-year outcome of patients treated for bifurcation coronary disease with provisional side branch T-stenting using drug-eluting stents. J Am Coll Cardiol Intv 2008 1 : 358 365.
4. Steigen TK, Maeng M, Wiseth R, et al., for the Nordic PCI Study Group. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: The Nordic Bifurcation study. Circulation 2006 114 : 1955 1961.
5. Pan M, Suárez de Lezo J, Medina A, et al. Drug-eluting stents for the treatment of bifurcation lesions: A randomized comparison between paclitaxel and sirolimus stents. Am Heart J 2007 153 : 15 17.
6. Miyazawa A, Ako J, Hongo Y, et al., for the ENDEAVOR III Investigators. Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: Intravascular ultrasound results from ENDEAVOR III. Am Heart J 2008 155 : 108 113.
7. Fajadet J, Wijns W, Laarman GJ, et al., for the ENDEAVOR II Investigators. Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: Clinical and angiographic results of the ENDEAVOR II trial. Circulation 2006 114 : 798 806.
8. Kandzari DE, Leon MB, Popma JJ, et al., for the ENDEAVOR III Investigators. Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: A randomized controlled trial. J Am Coll Cardiol 2006 48 : 2440 2447.
9. Medina A, Suarez de Lezo J, et al. A new classification of coronary bifurcation lesions. Rev Esp Cardiol 2006 59 : 183.
10. Pan M, Suarez de Lezo J, Medina A, et al. A stepwise strategy for the stent treatment of bifurcated coronary lesions. Catheter Cardiovasc Interv 2002 55 : 50 57. (Pubitemid 34008083)
11. Pan M, Suarez de Lezo J, Medina A, et al. Simple and complex stent strategies for bifurcated coronary arterial stenosis involving the side branch origin. Am J Cardiol 1999 83 : 1320 1325. (Pubitemid 29205739)
12. Yamashita T, Nishida T, Adamian MG, et al. Bifurcation lesions: Two stents versus one stent-immediate and follow-up results. J Am Coll Cardiol 2000 35 : 1145 1151. (Pubitemid 30206888)
13. Colombo A, Moses JW, Morice MC, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 2004 109 : 1244 1249. (Pubitemid 38372783)
14. Colombo A, Bramucci E, Saccà S, et al. Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations the CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) study. Circulation 2009 119 : 71 78.
15. Brunel P, Lefevre T, Darremont O, et al. Provisional T-stenting and kissing balloon in the treatment of coronary bifurcation lesions: Results of the French multicenter "TULIPE" study. Catheter Cardiovasc Interv 2006 68 (1 67 73. (Pubitemid 44024464)
16. Rux S, Sonntag S, Schulze R, et al., for the BISCOR Investigators. Acute and long-term results of bifurcation stenting (from the Coroflex Registry). Am J Cardiol 2006 98 (9 1214 1217. (Pubitemid 44584106)
17. Tanabe K, Hoye A, Lemos PA, et al. Re-stenosis rates following bifurcation stenting with sirolimus-eluting stents for De novo narrowings. Am J Cardiol 2004 91 : 115 118. (Pubitemid 38813465)
18. Thuesen L, Kelb H, Kløvgaard L, et al., for the SCANDSTENT Investigators. Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions: Subgroup analysis of the Stenting Coronary Arteries in Non-StressBenestent Disease Trial (SCANDSTENT). Am Heart J 2006 152 : 1140 1145. (Pubitemid 44872987)
19. Solinas E, Dangas G, Kirtane AJ, et al. Angiographic patterns of drug-eluting stent re-stenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention. Am J Cardiol 2008 102 : 311 315.
20. Park CB, Hong MK, Kim YH, et al. Comparison of angiographic patterns of in-stent re-stenosis between sirolimus- and paclitaxel-eluting stent. Int J Cardiol 2007 120 : 387 390.
21. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005 293 : 2126 2130. (Pubitemid 40617065)
22. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet 2007 369 : 6676 6678. (Pubitemid 46281313)
23. Airoldi F, Colombo A, Morici N, et al. Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment. Circulation 2007 116 : 745 754. (Pubitemid 47255992)
24. Miyazawa A, Ako J, Hongo Y, et al., for the ENDEAVOR III Investigators. Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: Intravascular ultrasound results from ENDEAVOR III. Am Heart J 2008 Jan 155 (1 108 q13. Epub 2007 Sep 14. (Pubitemid 350234763)
25. Sakurai R, Hongo Y, Yamasaki M, et al., for the ENDEAVOR II Trial Investigators. Detailed intravascular ultrasound analysis of Zotarolimus-eluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial). Am J Cardiol 2007 100 : 818 823.